Director/PDMR Shareholding

Spectris PLC

04 April 2025

 

Spectris plc: Director/PDMR Shareholding

This notification is made under Article 19 of the Market Abuse Regulation (EU) 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR").

On 4 April 2025, Spectris plc (the "Company") was notified that Derek Harding, President, Spectris Scientific, had acquired 4,796 ordinary shares, with a total aggregate price of £99,986.05 on 4 April 2025.

The form for these transactions, as required under MAR, follow:

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Derek Harding
2	Reason for the notification
a)	Position/status		Director/PDMR
b)	Initial notification/Amendment		Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Spectris plc
b)	LEI	213800Z4CO2CZO3M3T10
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary Shares of 5p each GB0003308607
b)	Nature of the transaction	Purchase of 3,741 shares at a price of £20.85 per ordinary share and 1,055 shares at a price of £20.84 per ordinary share.
c)	Price(s) and volume(s)	Price(s)		Volume(s)
		£20.85		3,741 ordinary shares
		£20.84		1,055 ordinary shares
d)	Aggregated information	Aggregated Volume		4,796
		Total Aggregate Price		£99,986.05
e)	Date of the transaction	4 April 2025
f)	Place of the transaction	London Stock Exchange:  LON

Name of contact and telephone number for queries:

Harriet Huband

Head of Secretariat

Tel: [phone]

For and on behalf of Spectris plc

LEI Number: 213800Z4CO2CZO3M3T10

Date: 4 April 2025

 

END